Hui Yu

Dr. Yu currently holds position in ACROBiosystems as Field Application Development Director. She received PhD in Biomedical science from University of Tennessee. She received her clinical trainings in Otorhinolaryngology back in China and transitioned to biomedical research on cell and gene therapy for blood disorders. Her latest industrial experience in is within cell process development on autologous hematopoietic stem cell drug (Casgevy) and multiple allogeneic CAR-T products (Phase I/II clinical trials).